B of A Securities Maintains Buy on Guardant Health, Raises Price Target to $40
Portfolio Pulse from Benzinga Newsdesk
B of A Securities analyst Michael Ryskin maintains a Buy rating on Guardant Health (NASDAQ:GH) and raises the price target from $28 to $40.
July 18, 2024 | 12:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
B of A Securities analyst Michael Ryskin maintains a Buy rating on Guardant Health and raises the price target from $28 to $40.
The Buy rating and increased price target from a reputable analyst at B of A Securities is likely to boost investor confidence in Guardant Health, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100